Shinbiosis Corporation

Solution

Our core competence is NanoGAS® technology, which enables the long-term stabilization of nano-scale bubbles over several years. In the healthcare sector, we have leveraged this technology to develop a pioneering Fecal Microbiota Transplantation (FMT) technique. Its efficacy and safety have been validated through "Specific Clinical Research" regarding its impact on Autism Spectrum Disorder (ASD). Furthermore, we have established robust clinical evidence, including a 50% reduction in healing time for pressure ulcers and a 50% decrease in the volume of laxatives required for endoscopic procedures. Beyond medicine, NanoGAS® provides superior oxidation inhibition (anti-corrosion) and antibacterial effects. With a proven track record in maintaining the hygiene of humidifiers, our technology is available for licensing and joint development to dramatically enhance the value of products across diverse fields—from healthcare to industrial and HVAC infrastructure.